Alcian Roofe-Stewart v MacIntyre Care Ltd
Decision date: 26 February 2025
Neutral citation: [2025] EAT 24
Overall AI summary confidence: medium
Short overview
This short overview is intended to summarise the case, issues and outcome so far as they are supported by the judgment.
AI confidence in this short overview: medium
This is an EAT appeal against a tribunal finding that the claimant (with MCTD) was not disabled under the Equality Act 2010 at the time of her 2021 dismissal. The EAT held the tribunal’s rejection of schedule 1 paragraph 2(2) (treating ceased effects as continuing if likely to recur) was insufficiently reasoned given the low threshold for "likely to recur" and the medical evidence of a fluctuating chronic condition. The EAT quashed the disability finding, allowed the appeal in part, and remitted the paragraph 2(2) issue to the tribunal with directions for refreshed case management and consideration of bespoke medical evidence.
Ratio decidendi
This summary is intended to identify the ratio decidendi, meaning the legal reasons for deciding and the binding part of the decision.
AI confidence in this ratio decidendi summary: medium
Where an impairment is quiescent, a tribunal must explicitly and properly apply the low legal threshold in schedule 1 paragraph 2(2) — asking whether the substantial adverse effect is likely to recur (i.e. "could well happen"); failure to address that question and to explain the reasoning renders the disability determination unsafe. Tribunals should also consider whether bespoke medical evidence addressing recurrence is reasonably required, particularly when the claimant is a litigant in person.
Obiter dicta
This summary is intended to identify obiter dicta, meaning observations made by the way that were not necessary to deciding the case and are not binding.
AI confidence in this obiter dicta summary: medium
The EAT suggested that tribunals should, where appropriate, hold case-management hearings to decide whether specialist reports should be directed to resolve specific legal-medical issues (such as likelihood of recurrence), and observed it is unrealistic to expect a litigant in person to identify the need for such specialist evidence without proactive case management.